Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) (PULSAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03496207
Recruitment Status : Recruiting
First Posted : April 12, 2018
Last Update Posted : February 25, 2019
Sponsor:
Information provided by (Responsible Party):
Acceleron Pharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2020
  Estimated Study Completion Date : November 2021